MREO 内幕交易
MREO 的 SEC Form 4 内幕交易记录
总交易
29
买入
0
买入总额
-
卖出总额
-
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(0) | JENKINS ANNALISA | - | 卖出 | 106,848 | - | - | 2026-02-26 | |
| ★★★★★(0) | JACQUET PIERRE | - | 卖出 | 106,848 | - | - | 2026-02-26 | |
| ★★★★★(0) | BENDER JEREMY | - | 卖出 | 117,533 | - | - | 2026-02-26 | |
| ★★★★★(0) | SHAMES DANIEL | - | 卖出 | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | EKBLOM ANDERS | - | 卖出 | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | YOSKOWITZ MARC J | - | 卖出 | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | WYZGA MICHAEL S | - | 卖出 | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | BENDER JEREMY | - | 卖出 | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | JENKINS ANNALISA | - | 卖出 | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | EKBLOM ANDERS | - | 卖出 | 133,560 | - | - | 2026-02-26 | |
| ★★★★★(0) | YOSKOWITZ MARC J | - | 卖出 | 96,163 | - | - | 2026-02-26 | |
| ★★★★★(0) | PAKIANATHAN DEEPIKA | - | 卖出 | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | SHAMES DANIEL | - | 卖出 | 96,163 | - | - | 2026-02-26 | |
| ★★★★★(0) | JACQUET PIERRE | - | 卖出 | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | LEWICKI JOHN A. | Chief Scientific Officer | 卖出 | 139,913 | - | - | 2026-02-01 | |
| ★★★★★(0) | SCOTS-KNIGHT DENISE | Chief Executive Officer | 卖出 | 345,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | LEWICKI JOHN A. | Chief Scientific Officer | 卖出 | 46,637 | - | - | 2026-02-01 | |
| ★★★★★(0) | FOX CHRISTINE ANN | Chief Financial Officer | 卖出 | 105,250 | - | - | 2026-02-01 | |
| ★★★★★(0) | HUGHES-WILSON ALEXANDRA | Chief Patient Access and Commercial Planning | 卖出 | 195,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | SERMON CHARLES | General Counsel | 卖出 | 315,750 | - | - | 2026-02-01 | |
| ★★★★★(0) | SERMON CHARLES | General Counsel | 卖出 | 295,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | SCOTS-KNIGHT DENISE | Chief Executive Officer | 卖出 | 480,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | SCOTS-KNIGHT DENISE | Chief Executive Officer | 卖出 | 1,035,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | HUGHES-WILSON ALEXANDRA | Chief Patient Access and Commercial Planning | 卖出 | 61,250 | - | - | 2026-02-01 | |
| ★★★★★(0) | FOX CHRISTINE ANN | Chief Financial Officer | 卖出 | 315,750 | - | - | 2026-02-01 | |
| ★★★★★(0) | HUGHES-WILSON ALEXANDRA | Chief Patient Access and Commercial Planning | 卖出 | 183,750 | - | - | 2026-02-01 | |
| ★★★★★(0) | FOX CHRISTINE ANN | Chief Financial Officer | 卖出 | 280,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | LEWICKI JOHN A. | Chief Scientific Officer | 卖出 | 145,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | SERMON CHARLES | General Counsel | 卖出 | 105,250 | - | - | 2026-02-01 |